A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)

Authors

Mark E. Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Mauricio R. Delgado, University of Texas Southwestern Medical Center, Dallas, TX
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Francoise Calvi-Gries, Ipsen, Boulogne-Billancourt, France
Jumaah Goldberg, Ipsen, Cambridge, MA

Document Type

Conference Proceeding

Publication Date

5-3-2022

Publication Title

Neurology

Abstract

74th Annual Meeting of the American Academy of Neurology, AAN 2022, April 24 - 26, 2022, Virtual

First Page

3224

Volume

98

Issue

18 Supplement

Comments

Abstract P13-5.002

Rights

© 2022, Wolters Kluwer Health

Recommended Citation

Gormley, Mark E.; Dabrowski, Edward; Delgado, Mauricio R.; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Calvi-Gries, Francoise; and Goldberg, Jumaah, "A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)" (2022). School of Medicine Faculty Publications. 4142.
https://digitalscholar.lsuhsc.edu/som_facpubs/4142
10.1212/WNL.98.18_supplement.322